Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunovant (IMVT) Change in Cash (2019 - 2026)

Immunovant filings provide 7 years of Change in Cash readings, the most recent being $472.7 million for Q4 2025.

  • Quarterly Change in Cash rose 581.04% to $472.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $619.8 million through Dec 2025, up 296.0% year-over-year, with the annual reading at $78.6 million for FY2025, 69.63% down from the prior year.
  • Change in Cash hit $472.7 million in Q4 2025 for Immunovant, up from -$77.0 million in the prior quarter.
  • Across five years, Change in Cash topped out at $472.7 million in Q4 2025 and bottomed at -$115.1 million in Q2 2025.
  • Average Change in Cash over 5 years is $28.6 million, with a median of -$39.9 million recorded in 2022.
  • The largest annual shift saw Change in Cash crashed 215.08% in 2022 before it surged 1468.88% in 2023.
  • Immunovant's Change in Cash stood at -$31.9 million in 2021, then skyrocketed by 183.99% to $26.8 million in 2022, then surged by 1468.88% to $421.0 million in 2023, then crashed by 123.34% to -$98.3 million in 2024, then surged by 581.04% to $472.7 million in 2025.
  • Per Business Quant, the three most recent readings for IMVT's Change in Cash are $472.7 million (Q4 2025), -$77.0 million (Q3 2025), and -$115.1 million (Q2 2025).